OBJECTIVE: Neurodegenerative and cerebrovascular conditions are common in old age and are associated with cognitive decline. However, considerable heterogeneity remains in residual decline (i.e., person-specific trajectories of cognitive decline adjusted for these common neuropathologic conditions). The present study aimed to characterize profiles of residual decline in late life cognition. METHOD: Up to 19 waves of longitudinal cognitive data were collected from 876 autopsied participants from 2 ongoing clinical-pathologic cohort studies of aging. Uniform neuropathologic examinations quantified measures of Alzheimer's disease, cerebral infarcts, Lewy body disease, and hippocampal sclerosis. Random effects mixture models characterized latent profiles of residual decline in global cognition. RESULTS: We identified 4 latent groups, and each group demonstrated distinct residual decline profiles. On average, 44% of the participants had little or no decline, 35% showed moderate decline, 13% showed severe decline and the rest (8%) had substantial within-subject fluctuation of longitudinal cognitive measures. These latent groups differed in psychological, experiential and neurobiologic factors that have been previously shown to be associated with cognitive decline. Specifically, compared with nondecliners, decliners had more depressive symptoms, were more socially isolated; were less engaged in cognitive or physical activities; and had lower density of noradrenergic neurons in locus ceruleus. CONCLUSIONS: After controlling for common dementia related pathologies, considerable residual variability remains in cognitive aging trajectories and this variability is not random but rather is related to markers of cognitive and neural reserve. The mixture modeling approach provides a powerful tool to identify latent groups with distinct cognitive trajectories. (c) 2015 APA, all rights reserved).
OBJECTIVE:Neurodegenerative and cerebrovascular conditions are common in old age and are associated with cognitive decline. However, considerable heterogeneity remains in residual decline (i.e., person-specific trajectories of cognitive decline adjusted for these common neuropathologic conditions). The present study aimed to characterize profiles of residual decline in late life cognition. METHOD: Up to 19 waves of longitudinal cognitive data were collected from 876 autopsied participants from 2 ongoing clinical-pathologic cohort studies of aging. Uniform neuropathologic examinations quantified measures of Alzheimer's disease, cerebral infarcts, Lewy body disease, and hippocampal sclerosis. Random effects mixture models characterized latent profiles of residual decline in global cognition. RESULTS: We identified 4 latent groups, and each group demonstrated distinct residual decline profiles. On average, 44% of the participants had little or no decline, 35% showed moderate decline, 13% showed severe decline and the rest (8%) had substantial within-subject fluctuation of longitudinal cognitive measures. These latent groups differed in psychological, experiential and neurobiologic factors that have been previously shown to be associated with cognitive decline. Specifically, compared with nondecliners, decliners had more depressive symptoms, were more socially isolated; were less engaged in cognitive or physical activities; and had lower density of noradrenergic neurons in locus ceruleus. CONCLUSIONS: After controlling for common dementia related pathologies, considerable residual variability remains in cognitive aging trajectories and this variability is not random but rather is related to markers of cognitive and neural reserve. The mixture modeling approach provides a powerful tool to identify latent groups with distinct cognitive trajectories. (c) 2015 APA, all rights reserved).
Authors: Robert S Wilson; Sukriti Nag; Patricia A Boyle; Loren P Hizel; Lei Yu; Aron S Buchman; Julie A Schneider; David A Bennett Journal: Neurology Date: 2013-03-13 Impact factor: 9.910
Authors: Charles DeCarli; Joseph Massaro; Danielle Harvey; John Hald; Mats Tullberg; Rhoda Au; Alexa Beiser; Ralph D'Agostino; Philip A Wolf Journal: Neurobiol Aging Date: 2005-04 Impact factor: 4.673
Authors: Juan C Troncoso; Alan B Zonderman; Susan M Resnick; Barbara Crain; Olga Pletnikova; Richard J O'Brien Journal: Ann Neurol Date: 2008-08 Impact factor: 10.422
Authors: Lei Yu; Patricia Boyle; Julie A Schneider; Eisuke Segawa; Robert S Wilson; Sue Leurgans; David A Bennett Journal: Psychol Aging Date: 2013-05-06
Authors: Jason Hassenstab; Rachel Chasse; Perri Grabow; Tammie L S Benzinger; Anne M Fagan; Chengjie Xiong; Mateusz Jasielec; Elizabeth Grant; John C Morris Journal: Neurobiol Aging Date: 2016-03-24 Impact factor: 4.673
Authors: Taylor J Krivanek; Seth A Gale; Brittany M McFeeley; Casey M Nicastri; Kirk R Daffner Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472
Authors: Zoe Arvanitakis; Sue E Leurgans; Debra A Fleischman; Julie A Schneider; Kumar B Rajan; Jeremy J Pruzin; Raj C Shah; Denis A Evans; Lisa L Barnes; David A Bennett Journal: Ann Neurol Date: 2018-03-30 Impact factor: 10.422
Authors: R J Kryscio; E L Abner; P T Nelson; D Bennett; J Schneider; L Yu; L S Hemmy; K O Lim; K Masaki; N Cairns; C Xiong; R Woltjer; H H Dodge; S Tyas; D W Fardo; W Lou; L Wan; F A Schmitt Journal: J Prev Alzheimers Dis Date: 2016-06
Authors: Michael J Lyons; Matthew S Panizzon; Weijian Liu; Ruth McKenzie; Noah J Bluestone; Michael D Grant; Carol E Franz; Eero P Vuoksimaa; Rosemary Toomey; Kristen C Jacobson; Chandra A Reynolds; William S Kremen; Hong Xian Journal: Dev Psychol Date: 2017-03-30
Authors: Kelsey D Biddle; Federico d'Oleire Uquillas; Heidi I L Jacobs; Benjamin Zide; Dylan R Kirn; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Nancy J Donovan Journal: Am J Geriatr Psychiatry Date: 2019-05-10 Impact factor: 4.105
Authors: Annie Robitaille; Ardo van den Hout; Robson J M Machado; David A Bennett; Iva Čukić; Ian J Deary; Scott M Hofer; Emiel O Hoogendijk; Martijn Huisman; Boo Johansson; Andriy V Koval; Maaike van der Noordt; Andrea M Piccinin; Judith J M Rijnhart; Archana Singh-Manoux; Johan Skoog; Ingmar Skoog; John Starr; Lisa Vermunt; Sean Clouston; Graciela Muniz Terrera Journal: Alzheimers Dement Date: 2018-02-01 Impact factor: 21.566
Authors: Lei Yu; Vladislav A Petyuk; Chris Gaiteri; Sara Mostafavi; Tracy Young-Pearse; Raj C Shah; Aron S Buchman; Julie A Schneider; Paul D Piehowski; Ryan L Sontag; Thomas L Fillmore; Tujin Shi; Richard D Smith; Philip L De Jager; David A Bennett Journal: Ann Neurol Date: 2018-07-03 Impact factor: 10.422
Authors: David A Bennett; Aron S Buchman; Patricia A Boyle; Lisa L Barnes; Robert S Wilson; Julie A Schneider Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472